Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea
· Delayed Price · Currency is KRW 14,260
+250 (1.78%)
Apr 29, 2026, 3:30 PM KST
KRX:271980 Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Market Capitalization | 207,790 | 220,758 | 166,115 | 249,173 | 306,002 | 494,458 | Upgrade
|
| Market Cap Growth | 5.40% | 32.90% | -33.33% | -18.57% | -38.11% | -45.95% | Upgrade
|
| Enterprise Value | 282,328 | 296,796 | 219,930 | 307,855 | 346,161 | 503,450 | Upgrade
|
| Last Close Price | 14260.00 | 15150.00 | 11400.00 | 17100.00 | 20937.61 | 33666.10 | Upgrade
|
| PE Ratio | 8.88 | 9.44 | - | 49.79 | - | - | Upgrade
|
| PS Ratio | 0.37 | 0.39 | 0.24 | 0.34 | 0.42 | 0.71 | Upgrade
|
| PB Ratio | 0.83 | 0.88 | 0.76 | 1.46 | 1.87 | 2.96 | Upgrade
|
| P/TBV Ratio | 1.03 | 1.09 | 0.91 | 1.62 | 1.99 | 3.01 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 35.94 | Upgrade
|
| P/OCF Ratio | - | - | 51.70 | - | - | 25.89 | Upgrade
|
| EV/Sales Ratio | 0.50 | 0.52 | 0.31 | 0.42 | 0.48 | 0.72 | Upgrade
|
| EV/EBITDA Ratio | 8.48 | 8.91 | - | 16.50 | - | - | Upgrade
|
| EV/EBIT Ratio | 13.45 | 14.14 | - | 34.64 | - | - | Upgrade
|
| EV/FCF Ratio | -20.57 | - | - | - | - | 36.60 | Upgrade
|
| Debt / Equity Ratio | 0.37 | 0.37 | 0.35 | 0.42 | 0.33 | 0.29 | Upgrade
|
| Debt / EBITDA Ratio | 2.80 | 2.80 | - | 3.82 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 3.48 | Upgrade
|
| Net Debt / Equity Ratio | 0.14 | 0.14 | 0.08 | 0.21 | 0.14 | 0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.04 | 1.04 | -2.51 | 1.90 | -5.12 | -15.87 | Upgrade
|
| Net Debt / FCF Ratio | -2.52 | -2.52 | -17.13 | -3.21 | -0.87 | 1.44 | Upgrade
|
| Asset Turnover | 1.10 | 1.10 | 1.39 | 1.54 | 1.64 | 1.68 | Upgrade
|
| Inventory Turnover | 3.39 | 3.39 | 4.92 | 5.19 | 5.61 | 5.15 | Upgrade
|
| Quick Ratio | 0.82 | 0.82 | 0.79 | 0.66 | 0.71 | 0.78 | Upgrade
|
| Current Ratio | 1.29 | 1.29 | 1.18 | 1.04 | 1.12 | 1.28 | Upgrade
|
| Return on Equity (ROE) | 13.61% | 13.61% | -15.45% | 3.11% | -9.06% | -8.82% | Upgrade
|
| Return on Assets (ROA) | 2.53% | 2.53% | -2.29% | 1.18% | -1.89% | -1.55% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.79% | 7.35% | -8.36% | 4.52% | -7.13% | -5.16% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.80% | 7.80% | -7.90% | 4.90% | -6.80% | -5.10% | Upgrade
|
| Earnings Yield | 11.25% | 10.59% | -18.04% | 2.01% | -4.28% | -2.52% | Upgrade
|
| FCF Yield | -6.60% | -6.22% | -0.64% | -4.45% | -8.57% | 2.78% | Upgrade
|
| Dividend Yield | - | - | - | 0.29% | 0.24% | - | Upgrade
|
| Payout Ratio | - | - | - | 14.55% | - | - | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.01% | 0.02% | 0.02% | 0.23% | 0.04% | Upgrade
|
| Total Shareholder Return | -0.01% | -0.01% | 0.02% | 0.31% | 0.47% | 0.04% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.